Casey Means’ financial disclosures show ties to supplement industry
Isabella Cueto, a writer and researcher focused on chronic diseases, sheds light on the latest controversy surrounding surgeon general nominee Casey Means. Means, a prominent figure in the health and wellness industry, has come under fire for her financial ties to supplements and other health products, raising concerns about potential conflicts of interest.
According to recent financial disclosures, Means has earned hundreds of thousands of dollars by promoting various supplements and wellness products. These details have sparked a debate about the transparency and integrity of her nomination, especially given her close relationships with key figures in the Trump administration, such as Medicaid director Mehmet Oz and health adviser Calley Means.
An investigation by the Associated Press revealed that Casey Means failed to disclose her partnerships with supplements companies and other businesses, despite actively promoting them through her newsletter and social media platforms. The disclosure of payments from companies like Apothekary, ENERGYbits, Florasophy, Pendulum Therapeutics, and others has raised concerns about her impartiality and commitment to public health.
The supplements industry has faced scrutiny for its connections to government officials, and Means’ financial disclosures only add fuel to the fire. With a total of over $130,000 in sponsorship fees from companies like Amazentis and a book tour sponsorship from another supplement company, the transparency of her actions is called into question.
As the nomination process for surgeon general progresses, it is crucial for lawmakers and the public to examine Means’ financial ties and assess whether they pose a conflict of interest. Isabella Cueto’s coverage of chronic diseases highlights the importance of transparency and accountability in the healthcare industry, especially when it comes to individuals tasked with promoting public health and wellness.
